Search Login Register

Glucagon-Like Peptide 1 (GLP 1) Summary

Description: A peptide of 36 or 37 amino acids that is derived from PROGLUCAGON and mainly produced by the INTESTINAL L CELLS. GLP-1(1-37 or 1-36) is further N-terminally truncated resulting in GLP-1(7-37) or GLP-1-(7-36) which can be amidated. These GLP-1 peptides are known to enhance glucose-dependent INSULIN release, suppress GLUCAGON release and gastric emptying, lower BLOOD GLUCOSE, and reduce food intake.

Also Known As: GLP 1; GLP-1; Glucagon-Like Peptide-1; Glucagon Like Peptide 1

Networked: 1984 relevant articles (204 outcomes, 287 trials/studies) for this Bio-Agent

Key Diseases for which Glucagon-Like Peptide 1 is Relevant

  1. Weight Loss (Weight Reduction) : 31 outcomes 25 studies in 231 results
  2. Body Weight (Weight, Body) : 26 outcomes 15 studies in 235 results
  3. Type 2 Diabetes Mellitus (MODY) : 25 outcomes 34 studies in 357 results
  4. Hyperglycemia : 18 outcomes 18 studies in 165 results
  5. Insulin Resistance : 15 outcomes 14 studies in 136 results
Show All >>

Drugs Related to Glucagon-Like Peptide 1

  1. Glucose (Dextrose)
  2. Insulin (Novolin)
  3. exenatide (Byetta)
  4. liraglutide
  5. Glucagon-Like Peptide 1 (GLP 1)
  6. Incretins
  7. Hormones
  8. Glucagon (Glukagon)
  9. Peptide YY
  10. Blood Glucose (Blood Sugar)
Show All >>

Therapies Related to Glucagon-Like Peptide 1

  1. Intravenous Infusions
  2. Bariatric Surgery
  3. Caloric Restriction
  4. Gastrectomy
  5. Gastric Bypass (Roux-en-Y Gastric Bypass)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.